Highmark, Boehringer Ingelheim Announce Value-Based Contract for COPD...

Highmark and Boehringer Ingelheim today announced a new value-based contract for Boehringer Ingelheim’s Stiolto® Respimat® (tiotropium bromide & olodaterol) Inhalation Spray for the...(PRWeb December 12, 2019)Read the full story at https://www.prweb.com/releases/highmark_boehringer_ingelheim_announce_value_based_contract_for_copd_medication_stiolto_respimat/prweb16782338.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news